PPBP and metabolic dysfunction-associated steatotic liver disease: Next, we also measured serum SAP and PPBP levels in patients with colorectal polyps without liver disease as a control group (Fig 3B) and in patients with chronic hepatitis B and nonalcoholic fatty liver disease (NAFLD) as a group of patients with other liver diseases.